Cilostazol Treatment
TIA, stroke, reduced dependence
STROKE, TIA
Cilostazol did not reduce the composite outcome, recurrent stroke or TIA, or improve QOL, global SIS, or global clinical outcome, but it reduced dependence (mRS score of 3-6: 13 of 147 [8.8%] with cilostazol vs 26 of 150 [17.3%] without; aOR, 0.31 [95% CI, 0.14 to 0.72]; 